Journal of endourology最新文献

筛选
英文 中文
Evaluating the Performance of ChatGPT in Urology: Comment. 评估 ChatGPT 在泌尿外科中的性能:评论。
IF 2.9 2区 医学
Journal of endourology Pub Date : 2024-07-10 DOI: 10.1089/end.2024.0373
Amnuay Kleebayoon, Viroj Wiwanitkit
{"title":"Evaluating the Performance of ChatGPT in Urology: Comment.","authors":"Amnuay Kleebayoon, Viroj Wiwanitkit","doi":"10.1089/end.2024.0373","DOIUrl":"10.1089/end.2024.0373","url":null,"abstract":"","PeriodicalId":15723,"journal":{"name":"Journal of endourology","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141468421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Robotic Platforms for Robot-Assisted Laparoscopic Surgery in Urology: A Narrative Review. 用于泌尿外科机器人辅助腹腔镜手术的新型机器人平台:综述。
IF 2.9 2区 医学
Journal of endourology Pub Date : 2024-07-01 Epub Date: 2024-05-28 DOI: 10.1089/end.2023.0732
Panagiotis Kallidonis, Kristiana Gkeka, Vasileios Tatanis, Paraskevi Katsakiori, Theofanis Vrettos, Evangelos Liatsikos
{"title":"Novel Robotic Platforms for Robot-Assisted Laparoscopic Surgery in Urology: A Narrative Review.","authors":"Panagiotis Kallidonis, Kristiana Gkeka, Vasileios Tatanis, Paraskevi Katsakiori, Theofanis Vrettos, Evangelos Liatsikos","doi":"10.1089/end.2023.0732","DOIUrl":"10.1089/end.2023.0732","url":null,"abstract":"<p><p>Robot-assisted surgery (RAS) has been integrated into clinical practice to overcome several limitations of conventional open or laparoscopic surgery. After the expiration of the long key patent period of Intuitive Surgical, various robotic systems (RSs) have been developed aiming at improving certain characteristics of the first robotic platform, the Da Vinci RS. This narrative review provides an overview of the current RSs used in urology along with the initial results from their application in urologic procedures. Nine robotic platforms are being analyzed regarding their unique characteristics as well as their efficacy, safety, feasibility, and outcomes in urologic, oncological, or non-oncological operations. The main barrier to the wide application of RAS has been the increased cost that refers to both acquisition and maintenance costs. Besides, the health inequality resulting from the lack of expert robotic surgeons and the difficulty of performing robot-assisted procedures in provincial hospitals should be overcome. However, large properly designed comparative studies are required to establish the role of newly introduced RSs. In addition, urologists should keep abreast of new developments and research in robot-assisted urologic procedures.</p>","PeriodicalId":15723,"journal":{"name":"Journal of endourology","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140957884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spotlight on Yasser A. Noureldin, MD, MSc, PhD, FEBU. 聚焦亚瑟-努雷尔丁(Yasser A. Noureldin),医学博士、理学硕士、哲学博士、FEBU。
IF 2.9 2区 医学
Journal of endourology Pub Date : 2024-07-01 DOI: 10.1089/end.2024.33779.spot
{"title":"Spotlight on Yasser A. Noureldin, MD, MSc, PhD, FEBU.","authors":"","doi":"10.1089/end.2024.33779.spot","DOIUrl":"https://doi.org/10.1089/end.2024.33779.spot","url":null,"abstract":"","PeriodicalId":15723,"journal":{"name":"Journal of endourology","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative Outcomes and Complication Rates in Holmium Laser Enucleation of the Prostate Patients After Prior Prostate Biopsy-Does It Really Make a Difference? A Propensity Score Matched Analysis. 既往前列腺活检术后HoLEP患者的围手术期结果和并发症发生率--真的有区别吗?倾向得分匹配分析。
IF 2.9 2区 医学
Journal of endourology Pub Date : 2024-07-01 Epub Date: 2024-05-21 DOI: 10.1089/end.2024.0008
Friedrich Otto Hartung, Luisa Egen, Britta Grüne, Christopher Netsch, Paul Patroi, Maximilian Christian Kriegmair, Jost von Hardenberg, Marie-Claire Rassweiler-Seyfried, Maurice Stephan Michel, Maren Julianne Wenk, Jonas Herrmann
{"title":"Perioperative Outcomes and Complication Rates in Holmium Laser Enucleation of the Prostate Patients After Prior Prostate Biopsy-Does It Really Make a Difference? A Propensity Score Matched Analysis.","authors":"Friedrich Otto Hartung, Luisa Egen, Britta Grüne, Christopher Netsch, Paul Patroi, Maximilian Christian Kriegmair, Jost von Hardenberg, Marie-Claire Rassweiler-Seyfried, Maurice Stephan Michel, Maren Julianne Wenk, Jonas Herrmann","doi":"10.1089/end.2024.0008","DOIUrl":"10.1089/end.2024.0008","url":null,"abstract":"<p><p><b><i>Introduction:</i></b> Before holmium laser enucleation of the prostate (HoLEP), many patients have undergone short-term prostate biopsy (PB) to rule out the presence of prostate cancer. The aim of this study is to determine whether a short-term PB before HoLEP has an impact on the perioperative outcomes or complications of HoLEP. <b><i>Methods:</i></b> In total, 734 consecutive patients treated with HoLEP at a tertiary care university hospital between January 2021 and July 2023 were retrospectively enrolled. Patients who had PB within 6 months before HoLEP were matched to patients who underwent PB more than 6 months or had no PB before HoLEP using propensity score matching (PSM) based on age, prostate volume (PV), prostate-specific antigen (PSA), preoperative urinary tract infection (UTI), and surgeon. Perioperative parameters, such as operation time (OT), enucleation efficiency (EF), as well as complications according to the Satava classification, the Clavien-Dindo classification (CDC), and the Comprehensive Complication Index (CCI) were evaluated. <b><i>Results:</i></b> In total, 206 patients were matched. Age, PV, PSA, as well as the presence of a preoperative UTI and surgeons did not differ significantly between both groups after PSM. There were no significant differences in mean OT (75 vs. 81 minutes, <i>p</i> = 0.28) and EF (2.13 vs. 2.13 g/min, <i>p</i> = 0.99). No differences were noted regarding intraoperative (16 vs. 25, <i>p</i> = 0.16) or postoperative complications graded by CDC (<i>p</i> = 0.53) and CCI (<i>p</i> = 0.92). <b><i>Conclusion:</i></b> PB within 6 months preoperatively before HoLEP showed no effect on perioperative outcomes or intra- and postoperative complications.</p>","PeriodicalId":15723,"journal":{"name":"Journal of endourology","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140891926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating Acetate as a Renoprotective Agent After Kidney Ischemia in a Porcine Model. 在猪模型中评估醋酸盐作为肾缺血后的肾保护剂。
IF 2.9 2区 医学
Journal of endourology Pub Date : 2024-07-01 Epub Date: 2024-06-07 DOI: 10.1089/end.2023.0289
Hal D Kominsky, Jessica C Dai, Tara N Morgan, Alaina Garbens, Ryan L Steinberg, Jeffrey A Cadeddu
{"title":"Evaluating Acetate as a Renoprotective Agent After Kidney Ischemia in a Porcine Model.","authors":"Hal D Kominsky, Jessica C Dai, Tara N Morgan, Alaina Garbens, Ryan L Steinberg, Jeffrey A Cadeddu","doi":"10.1089/end.2023.0289","DOIUrl":"10.1089/end.2023.0289","url":null,"abstract":"<p><p><b><i>Objective:</i></b> Renoprotection from reperfusion injury appears to be conferred by HIF-2a activation, which can be stimulated by exogenous acetate administration. The study objective was to assess whether administration of acetate in a porcine model can mitigate kidney injury related to ischemia-reperfusion after renal hilar occlusion. <b><i>Methods:</i></b> A porcine single-kidney model was created by performing a laparoscopic nephrectomy followed by animal recovery. After 2 days, the animals underwent laparoscopic hilar dissection. Block randomization was used to assign pigs into one of four experimental groups. One treatment block of pigs received 150 mEq of sodium acetate intravenously during 90 minutes of en bloc occlusion of the renal hilum (herein noted as \"cross-clamping\"). Another block received 0.75 g/kg of oral sodium acetate for 3 days prior to cross-clamping. A third block received no acetate and underwent hilar dissection without cross-clamping (negative control). The final block received no acetate and underwent cross-clamping (positive control). Serum creatinine was used to estimate renal function post-nephrectomy. <b><i>Results:</i></b> A total of 16 animals (4 pigs in each group) completed the study protocol. Median pig weight was 34.6 kg. One pig receiving IV acetate was excluded from the final analysis because of unrecoverable renal failure after cross-clamping. There was a significantly lower mean serum creatinine for the IV acetate group compared with the positive control group 72 hours after cross-clamping (<i>p</i> = 0.012). The same effect was not observed for the pigs receiving oral acetate. By day 7, renal function had recovered without significant difference in all groups. <b><i>Conclusions:</i></b> We observed that the administration of intravenous acetate conferred a significant renoprotective benefit in our single kidney ischemia-reperfusion porcine model 72 hours after hilar occlusion. This work is hypothesis-generating, and further work in human subjects undergoing renal hilar occlusion during partial nephrectomy is warranted.</p>","PeriodicalId":15723,"journal":{"name":"Journal of endourology","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140957834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the Crystal Clear: Cone Beam Computed Tomography's Role in Enhancing PCNL Outcomes and the Path Forward. 揭开水晶般清晰的面纱:锥形束计算机断层扫描在提高 PCNL 结果中的作用及前进之路。
IF 2.9 2区 医学
Journal of endourology Pub Date : 2024-06-25 DOI: 10.1089/end.2024.0235
Fu-Xiang Lin, Yi Yu, Zhan-Ping Xu
{"title":"Unveiling the Crystal Clear: Cone Beam Computed Tomography's Role in Enhancing PCNL Outcomes and the Path Forward.","authors":"Fu-Xiang Lin, Yi Yu, Zhan-Ping Xu","doi":"10.1089/end.2024.0235","DOIUrl":"10.1089/end.2024.0235","url":null,"abstract":"","PeriodicalId":15723,"journal":{"name":"Journal of endourology","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond ChatGPT: It Is Time to Focus More on Specialized Medical LLMs. 超越 ChatGPT:是时候更加关注专业医学法律硕士了。
IF 2.7 2区 医学
Journal of endourology Pub Date : 2024-06-18 DOI: 10.1089/end.2024.0374
Shuo Wang
{"title":"Beyond ChatGPT: It Is Time to Focus More on Specialized Medical LLMs.","authors":"Shuo Wang","doi":"10.1089/end.2024.0374","DOIUrl":"10.1089/end.2024.0374","url":null,"abstract":"","PeriodicalId":15723,"journal":{"name":"Journal of endourology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Professor Dr. Akhil Das, MD University of California at Irvine. 加州大学欧文分校医学博士 Akhil Das 教授。
IF 2.7 2区 医学
Journal of endourology Pub Date : 2024-06-01 DOI: 10.1089/end.2024.29149.spot
{"title":"Professor Dr. Akhil Das, MD University of California at Irvine.","authors":"","doi":"10.1089/end.2024.29149.spot","DOIUrl":"10.1089/end.2024.29149.spot","url":null,"abstract":"","PeriodicalId":15723,"journal":{"name":"Journal of endourology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141199326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intermediate-Term Oncologic Outcome Assessment for Robot-Assisted Radical Prostatectomy: Comparing Retzius-Sparing with Standard Approach in a Randomized Control Cohort. 机器人辅助根治性前列腺切除术的中期肿瘤学结果评估:在随机对照队列中比较 Retzius Sparing 和标准方法。
IF 2.9 2区 医学
Journal of endourology Pub Date : 2024-06-01 DOI: 10.1089/end.2023.0514
Ghassan A Barayan, Sami E Majdalany, Mohit Butaney, Deepansh Dalela, James Peabody, Firas Abdolla, Mani Menon, Wooju Jeong
{"title":"Intermediate-Term Oncologic Outcome Assessment for Robot-Assisted Radical Prostatectomy: Comparing Retzius-Sparing with Standard Approach in a Randomized Control Cohort.","authors":"Ghassan A Barayan, Sami E Majdalany, Mohit Butaney, Deepansh Dalela, James Peabody, Firas Abdolla, Mani Menon, Wooju Jeong","doi":"10.1089/end.2023.0514","DOIUrl":"10.1089/end.2023.0514","url":null,"abstract":"<p><p><b><i>Introduction:</i></b> Retzius-sparing prostatectomy was promoted with the early continence result. The long-term oncologic outcome is still unknown. In this study, we aimed to compare the intermediate-term oncologic outcomes of these two approaches in patients' cohort who were treated as part of a randomized controlled trial. <b><i>Methods:</i></b> A total of 120 patients were previously randomized equally to receive Retzius-sparing robot-assisted laparoscopic radical prostatectomy (RS-RARP) <i>vs</i> standard robot-assisted laparoscopic radical prostatectomy (S-RARP) between January 2015 and April 2016. Baseline, surgical, and pathologic characteristics as well as oncologic outcomes were assessed. The analysis was done based on the treatment received. <b><i>Result:</i></b> Sixty-three patients underwent S-RARP, whereas 57 patients underwent RS-RARP. There was no statistically significant difference in the baseline nor surgical characteristics. The median follow-up was 71.24 (interquartile range: 59.75-75.75) months. There were more pathologic T3 diseases in RS-RARP. There was no significant difference in the positive margin status nor in the biochemical recurrence (BCR) rate among both groups. After S-RARP and RS-RARP, 6 and 10 patients had BCR, and the 5 years BCR-free survival was 91% and 85%, respectively (<i>p</i> = 0.21). <b><i>Conclusion:</i></b> In this cohort, there was no difference in BCR in the patients who received either technique. Further multi-institutional studies with a larger sample size and longer follow-up are required.</p>","PeriodicalId":15723,"journal":{"name":"Journal of endourology","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140012701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Feasibility and Safety of the Toumai® Robotic System in Urologic Surgery: Initial Experience. 评估 Toumai® 机器人系统在泌尿外科手术中的可行性和安全性:初步经验。
IF 2.9 2区 医学
Journal of endourology Pub Date : 2024-06-01 DOI: 10.1089/end.2024.0028
Gaurab Pokhrel, Haoke Zheng, Jin Tao, Jinshan Cui, Yafeng Fan, Zhenhao Li, Biao Dong, Shuanbao Yu, Xuepei Zhang
{"title":"Assessing the Feasibility and Safety of the Toumai<sup>®</sup> Robotic System in Urologic Surgery: Initial Experience.","authors":"Gaurab Pokhrel, Haoke Zheng, Jin Tao, Jinshan Cui, Yafeng Fan, Zhenhao Li, Biao Dong, Shuanbao Yu, Xuepei Zhang","doi":"10.1089/end.2024.0028","DOIUrl":"10.1089/end.2024.0028","url":null,"abstract":"<p><p><b><i>Introduction:</i></b> Robotic surgery using da Vinci surgical system has gained prominence in urology; emerging robotic platforms are expanding its applications and increasing affordability. We assess the feasibility and safety of a novel system, the Toumai<sup>®</sup> robotic system in various urological surgeries. <b><i>Methods:</i></b> This prospective study was conducted at the first affiliated hospital of Zhengzhou university. Twenty consecutive patients underwent renal and prostatic surgery with the Toumai. The study assessed technical feasibility (conversion rate) and safety (perioperative complications) of the procedures as primary outcomes. Secondary endpoints included key surgical perioperative outcomes: functional and oncologic results. The Endoscopic Surgical System operates within a master-slave protocol, comprising a Surgeon Console, Patient Platform, and Vision Platform. <b><i>Results:</i></b> Seventeen patients underwent various nephrectomy procedures and three underwent radical prostatectomy (RP). There was no conversion to alternative surgical approach; a single (Clavien-Dindo grade ≥3b) complication occurred, and no readmission was recorded within 30 days. The median operative time was 120, 140, and 210 minutes for partial nephrectomy (PN), radical nephrectomy, and RP, respectively. Off-clamp PN was performed in one case, and the warm ischemia time in the remaining two case was 18 minutes. The median docking time was 22 minutes for nephrectomy and 20 minutes for RP; no major robotic malfunction was encountered. At 3-month follow-up, no tumor recurrence was recorded, renal function was well preserved, and the continence status was satisfactory. <b><i>Conclusions:</i></b> We present the initial clinical utilization of an innovative robotic platform. Complex urological surgeries were successfully completed without conversions and with minimal complications. Further investigations are warranted to confirm these initial findings.</p>","PeriodicalId":15723,"journal":{"name":"Journal of endourology","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140101708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信